{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:21:21Z","timestamp":1790457681240,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fanconi Anemia (FA), due to the loss-of-function of the proteins that constitute the FANC pathway involved in DNA replication and genetic stability maintainance, is a rare genetic disease featuring bone marrow failure, developmental abnormalities and cancer predisposition. Similar clinical stigmas have also been associated with alterations in the senescence program, which is activated in physiological or stress situations, including the unscheduled, chronic, activation of an oncogene (oncogene induced senescence, OIS). Here, we wanted to determine the crosstalk, if any, between the FANC pathway and the OIS process. OIS was analyzed in two known cellular models, IMR90-hTERT\/ER:RAS<jats:sup>G12V<\/jats:sup> and WI38-hTERT\/ER:GFP:RAF1, harboring 4-hydroxytamoxifen-inducible oncogenes. We observed that oncogene activation induces a transitory increase of both FANCA and FANCD2 as well as FANCD2 monoubiquitination, readout of FANC pathway activation, followed by their degradation. FANCD2 depletion, which leads to a pre-senescent phenotype, anticipates OIS progression. Coherently, FANCD2 overexpression or inhibition of its proteosomal-dependent degradation slightly delays OIS progression. The pro-senescence protease cathepsin L, which activation is anticipated during OIS in FANCD2-depleted cells, also participates to FANCD2 degradation. Our results demonstrate that oncogene activation is first associated with FANCD2 induction and activation, which may support initial cell proliferation, followed by its degradation\/downregulation when OIS proceeds.<\/jats:p>","DOI":"10.1038\/s41598-019-53502-w","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:04:13Z","timestamp":1574161453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fanconi anemia proteins counteract the implementation of the oncogene-induced senescence program"],"prefix":"10.1038","volume":"9","author":[{"given":"Anne","family":"Helbling-Leclerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Dessarps-Freichey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Evrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Rosselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"53502_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.gde.2010.10.005","volume":"21","author":"J Campisi","year":"2011","unstructured":"Campisi, J. Cellular senescence: putting the paradoxes in perspective. Curr Opin Genet Dev 21, 107\u2013112, https:\/\/doi.org\/10.1016\/j.gde.2010.10.005 (2011).","journal-title":"Curr Opin Genet Dev"},{"key":"53502_CR2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","volume":"75","author":"JA Campisi","year":"2013","unstructured":"Campisi, J. A. cellular senescence, and cancer. Annu Rev Physiol 75, 685\u2013705, https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183653 (2013).","journal-title":"Annu Rev Physiol"},{"key":"53502_CR3","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1101\/gad.1971610","volume":"24","author":"T Kuilman","year":"2010","unstructured":"Kuilman, T., Michaloglou, C., Mooi, W. J. & Peeper, D. S. The essence of senescence. Genes Dev 24, 2463\u20132479, https:\/\/doi.org\/10.1101\/gad.1971610 (2010).","journal-title":"Genes Dev"},{"key":"53502_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1083\/jcb.201009094","volume":"192","author":"F Rodier","year":"2011","unstructured":"Rodier, F. & Campisi, J. Four faces of cellular senescence. J Cell Biol 192, 547\u2013556, https:\/\/doi.org\/10.1083\/jcb.201009094 (2011).","journal-title":"J Cell Biol"},{"key":"53502_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nrm2233","volume":"8","author":"J Campisi","year":"2007","unstructured":"Campisi, J. & d\u2019Adda di Fagagna, F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8, 729\u2013740, https:\/\/doi.org\/10.1038\/nrm2233 (2007).","journal-title":"Nat Rev Mol Cell Biol"},{"key":"53502_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2007.07.003","volume":"130","author":"M Collado","year":"2007","unstructured":"Collado, M., Blasco, M. A. & Serrano, M. Cellular senescence in cancer and aging. Cell 130, 223\u2013233, https:\/\/doi.org\/10.1016\/j.cell.2007.07.003 (2007).","journal-title":"Cell"},{"key":"53502_CR7","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0959-8049(96)00058-5","volume":"33","author":"J Campisi","year":"1997","unstructured":"Campisi, J. The biology of replicative senescence. Eur J Cancer 33, 703\u2013709, https:\/\/doi.org\/10.1016\/S0959-8049(96)00058-5 (1997).","journal-title":"Eur J Cancer"},{"key":"53502_CR8","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1073\/pnas.92.10.4337","volume":"92","author":"Q Chen","year":"1995","unstructured":"Chen, Q., Fischer, A., Reagan, J. D., Yan, L. J. & Ames, B. N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc Natl Acad Sci USA 92, 4337\u20134341 (1995).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53502_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature03841","volume":"436","author":"M Braig","year":"2005","unstructured":"Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660\u2013665, https:\/\/doi.org\/10.1038\/nature03841 (2005).","journal-title":"Nature"},{"key":"53502_CR10","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/436642a","volume":"436","author":"M Collado","year":"2005","unstructured":"Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642, https:\/\/doi.org\/10.1038\/436642a (2005).","journal-title":"Nature"},{"key":"53502_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nature03890","volume":"436","author":"C Michaloglou","year":"2005","unstructured":"Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720\u2013724, https:\/\/doi.org\/10.1038\/nature03890 (2005).","journal-title":"Nature"},{"key":"53502_CR12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cell.2013.10.019","volume":"155","author":"D Munoz-Espin","year":"2013","unstructured":"Munoz-Espin, D. et al. Programmed cell senescence during mammalian embryonic development. Cell 155, 1104\u20131118, https:\/\/doi.org\/10.1016\/j.cell.2013.10.019 (2013).","journal-title":"Cell"},{"key":"53502_CR13","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.15252\/embr.201439245","volume":"15","author":"BG Childs","year":"2014","unstructured":"Childs, B. G., Baker, D. J., Kirkland, J. L., Campisi, J. & van Deursen, J. M. Senescence and apoptosis: dueling or complementary cell fates? EMBO Rep 15, 1139\u20131153, https:\/\/doi.org\/10.15252\/embr.201439245 (2014).","journal-title":"EMBO Rep"},{"key":"53502_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbcan.2015.10.001","volume":"1865","author":"MK Ruhland","year":"2016","unstructured":"Ruhland, M. K., Coussens, L. M. & Stewart, S. A. Senescence and cancer: An evolving inflammatory paradox. Biochim Biophys Acta 1865, 14\u201322, https:\/\/doi.org\/10.1016\/j.bbcan.2015.10.001 (2016).","journal-title":"Biochim Biophys Acta"},{"key":"53502_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ejca.2004.10.015","volume":"41","author":"S Gandini","year":"2005","unstructured":"Gandini, S. et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41, 28\u201344, https:\/\/doi.org\/10.1016\/j.ejca.2004.10.015 (2005).","journal-title":"Eur J Cancer"},{"key":"53502_CR16","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature05268","volume":"444","author":"J Bartkova","year":"2006","unstructured":"Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633\u2013637, https:\/\/doi.org\/10.1038\/nature05268 (2006).","journal-title":"Nature"},{"key":"53502_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/ncb2879","volume":"15","author":"HA Cruickshanks","year":"2013","unstructured":"Cruickshanks, H. A. et al. Senescent cells harbour features of the cancer epigenome. Nat Cell Biol 15, 1495\u20131506, https:\/\/doi.org\/10.1038\/ncb2879 (2013).","journal-title":"Nat Cell Biol"},{"key":"53502_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature05327","volume":"444","author":"R Di Micco","year":"2006","unstructured":"Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638\u2013642, https:\/\/doi.org\/10.1038\/nature05327 (2006).","journal-title":"Nature"},{"key":"53502_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.molcel.2013.09.001","volume":"52","author":"GP Gupta","year":"2013","unstructured":"Gupta, G. P. et al. The Mre11 complex suppresses oncogene-driven breast tumorigenesis and metastasis. Mol Cell 52, 353\u2013365, https:\/\/doi.org\/10.1016\/j.molcel.2013.09.001 (2013).","journal-title":"Mol Cell"},{"key":"53502_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.gde.2015.07.002","volume":"33","author":"M Bogliolo","year":"2015","unstructured":"Bogliolo, M. & Surralles, J. Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics. Curr Opin Genet Dev 33, 32\u201340, https:\/\/doi.org\/10.1016\/j.gde.2015.07.002 (2015).","journal-title":"Curr Opin Genet Dev"},{"issue":"3","key":"53502_CR21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12185-017-2283-4","volume":"106","author":"Ronald S. Cheung","year":"2017","unstructured":"Cheung, R. S. & Taniguchi, T. Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers. Int J Hematol, https:\/\/doi.org\/10.1007\/s12185-017-2283-4 (2017).","journal-title":"International Journal of Hematology"},{"key":"53502_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep36539","volume":"6","author":"J Bourseguin","year":"2016","unstructured":"Bourseguin, J. et al. FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells. Sci Rep 6, 36539, https:\/\/doi.org\/10.1038\/srep36539 (2016).","journal-title":"Sci Rep"},{"key":"53502_CR23","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1590\/1678-4685-GMB-2016-0213","volume":"40","author":"A Gueiderikh","year":"2017","unstructured":"Gueiderikh, A., Rosselli, F. & Neto, J. B. C. A never-ending story: the steadily growing family of the FA and FA-like genes. Genet Mol Biol 40, 398\u2013407, https:\/\/doi.org\/10.1590\/1678-4685-GMB-2016-0213 (2017).","journal-title":"Genet Mol Biol"},{"key":"53502_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.molcel.2013.07.023","volume":"51","author":"G Lossaint","year":"2013","unstructured":"Lossaint, G. et al. FANCD2 binds MCM proteins and controls replisome function upon activation of s phase checkpoint signaling. Mol Cell 51, 678\u2013690, https:\/\/doi.org\/10.1016\/j.molcel.2013.07.023 (2013).","journal-title":"Mol Cell"},{"key":"53502_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.dnarep.2016.02.007","volume":"43","author":"J Sarkar","year":"2016","unstructured":"Sarkar, J. & Liu, Y. Fanconi anemia proteins in telomere maintenance. DNA Repair (Amst) 43, 107\u2013112, https:\/\/doi.org\/10.1016\/j.dnarep.2016.02.007 (2016).","journal-title":"DNA Repair (Amst)"},{"key":"53502_CR26","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.1182\/blood-2011-09-381970","volume":"119","author":"W Du","year":"2012","unstructured":"Du, W. et al. The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters. Blood 119, 4142\u20134151, https:\/\/doi.org\/10.1182\/blood-2011-09-381970 (2012).","journal-title":"Blood"},{"key":"53502_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/onc.2012.583","volume":"33","author":"U Kumari","year":"2014","unstructured":"Kumari, U., Ya Jun, W., Huat Bay, B. & Lyakhovich, A. Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells. Oncogene 33, 165\u2013172, https:\/\/doi.org\/10.1038\/onc.2012.583 (2014).","journal-title":"Oncogene"},{"key":"53502_CR28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1182\/blood-2009-07-234385","volume":"115","author":"J Li","year":"2010","unstructured":"Li, J., Du, W., Maynard, S., Andreassen, P. R. & Pang, Q. Oxidative stress-specific interaction between FANCD2 and FOXO3a. Blood 115, 1545\u20131548, https:\/\/doi.org\/10.1182\/blood-2009-07-234385 (2010).","journal-title":"Blood"},{"key":"53502_CR29","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1101\/gad.519709","volume":"23","author":"AR Young","year":"2009","unstructured":"Young, A. R. et al. Autophagy mediates the mitotic senescence transition. Genes Dev 23, 798\u2013803, https:\/\/doi.org\/10.1101\/gad.519709 (2009).","journal-title":"Genes Dev"},{"key":"53502_CR30","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1038\/onc.2011.481","volume":"31","author":"M Jeanblanc","year":"2012","unstructured":"Jeanblanc, M. et al. Parallel pathways in RAF-induced senescence and conditions for its reversion. Oncogene 31, 3072\u20133085, https:\/\/doi.org\/10.1038\/onc.2011.481 (2012).","journal-title":"Oncogene"},{"key":"53502_CR31","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1038\/emboj.2011.225","volume":"30","author":"I Gonzalez-Suarez","year":"2011","unstructured":"Gonzalez-Suarez, I. et al. A new pathway that regulates 53BP1 stability implicates cathepsin L and vitamin D in DNA repair. EMBO J 30, 3383\u20133396, https:\/\/doi.org\/10.1038\/emboj.2011.225 (2011).","journal-title":"EMBO J"},{"key":"53502_CR32","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1038\/onc.2016.77","volume":"35","author":"S Graziano","year":"2016","unstructured":"Graziano, S., Johnston, R., Deng, O., Zhang, J. & Gonzalo, S. Vitamin D\/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence. Oncogene 35, 5362\u20135376, https:\/\/doi.org\/10.1038\/onc.2016.77 (2016).","journal-title":"Oncogene"},{"key":"53502_CR33","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1093\/hmg\/11.21.2531","volume":"11","author":"P Pichierri","year":"2002","unstructured":"Pichierri, P., Averbeck, D. & Rosselli, F. DNA cross-link-dependent RAD50\/MRE11\/NBS1 subnuclear assembly requires the Fanconi anemia C protein. Hum Mol Genet 11, 2531\u20132546 (2002).","journal-title":"Hum Mol Genet"},{"key":"53502_CR34","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/nar\/gkv1019","volume":"44","author":"E Renaud","year":"2016","unstructured":"Renaud, E., Barascu, A. & Rosselli, F. Impaired TIP60-mediated H4K16 acetylation accounts for the aberrant chromatin accumulation of 53BP1 and RAP80 in Fanconi anemia pathway-deficient cells. Nucleic Acids Res 44, 648\u2013656, https:\/\/doi.org\/10.1093\/nar\/gkv1019 (2016).","journal-title":"Nucleic Acids Res"},{"key":"53502_CR35","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1242\/jcs.204909","volume":"130","author":"R Sumpter Jr.","year":"2017","unstructured":"Sumpter, R. Jr. & Levine, B. Emerging functions of the Fanconi anemia pathway at a glance. J Cell Sci 130, 2657\u20132662, https:\/\/doi.org\/10.1242\/jcs.204909 (2017).","journal-title":"J Cell Sci"},{"key":"53502_CR36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mrrev.2016.06.004","volume":"769","author":"X Renaudin","year":"2016","unstructured":"Renaudin, X., Koch Lerner, L., Menck, C. F. & Rosselli, F. The ubiquitin family meets the Fanconi anemia proteins. Mutat Res Rev Mutat Res 769, 36\u201346, https:\/\/doi.org\/10.1016\/j.mrrev.2016.06.004 (2016).","journal-title":"Mutat Res Rev Mutat Res"},{"key":"53502_CR37","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1242\/jcs.150706","volume":"127","author":"X Renaudin","year":"2014","unstructured":"Renaudin, X., Guervilly, J. H., Aoufouchi, S. & Rosselli, F. Proteomic analysis reveals a FANCA-modulated neddylation pathway involved in CXCR5 membrane targeting and cell mobility. J Cell Sci 127, 3546\u20133554, https:\/\/doi.org\/10.1242\/jcs.150706 (2014).","journal-title":"J Cell Sci"},{"key":"53502_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.tig.2017.11.006","volume":"34","author":"R Che","year":"2018","unstructured":"Che, R., Zhang, J., Nepal, M., Han, B. & Fei, P. Multifaceted Fanconi Anemia Signaling. Trends Genet 34, 171\u2013183, https:\/\/doi.org\/10.1016\/j.tig.2017.11.006 (2018).","journal-title":"Trends Genet"},{"key":"53502_CR39","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1182\/blood-2007-07-099218","volume":"111","author":"D Briot","year":"2008","unstructured":"Briot, D., Mace-Aime, G., Subra, F. & Rosselli, F. Aberrant activation of stress-response pathways leads to TNF-alpha oversecretion in Fanconi anemia. Blood 111, 1913\u20131923, https:\/\/doi.org\/10.1182\/blood-2007-07-099218 (2008).","journal-title":"Blood"},{"key":"53502_CR40","doi-asserted-by":"publisher","first-page":"e23324","DOI":"10.1371\/journal.pone.0023324","volume":"6","author":"N Matsushita","year":"2011","unstructured":"Matsushita, N. et al. Direct inhibition of TNF-alpha promoter activity by Fanconi anemia protein FANCD2. PLoS One 6, e23324, https:\/\/doi.org\/10.1371\/journal.pone.0023324 (2011).","journal-title":"PLoS One"},{"key":"53502_CR41","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1182\/blood.V83.5.1216.1216","volume":"83","author":"F Rosselli","year":"1994","unstructured":"Rosselli, F., Sanceau, J., Gluckman, E., Wietzerbin, J. & Moustacchi, E. Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha. Blood 83, 1216\u20131225 (1994).","journal-title":"Blood"},{"key":"53502_CR42","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/hmg\/ddr103","volume":"20","author":"JH Guervilly","year":"2011","unstructured":"Guervilly, J. H., Renaud, E., Takata, M. & Rosselli, F. USP1 deubiquitinase maintains phosphorylated CHK1 by limiting its DDB1-dependent degradation. Hum Mol Genet 20, 2171\u20132181, https:\/\/doi.org\/10.1093\/hmg\/ddr103 (2011).","journal-title":"Hum Mol Genet"},{"key":"53502_CR43","doi-asserted-by":"publisher","first-page":"27661","DOI":"10.18632\/oncotarget.15742","volume":"8","author":"DJ Baker","year":"2017","unstructured":"Baker, D. J., Alimirah, F., van Deursen, J. M., Campisi, J. & Hildesheim, J. Oncogenic senescence: a multi-functional perspective. Oncotarget 8, 27661\u201327672, https:\/\/doi.org\/10.18632\/oncotarget.15742 (2017).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53502-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53502-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:06:52Z","timestamp":1671293212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53502-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53502"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53502-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"26 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17024"}}